MA28553B1 - 2-{[2-(2-methylamino-pyrimidine-4-yl)-1h-indole-5-carbonyle]-amine} -3-(phenylpyridine-2-yl-amine)-acide propionique substantiellement pur comme inhibiteur de kinase ikb - Google Patents

2-{[2-(2-methylamino-pyrimidine-4-yl)-1h-indole-5-carbonyle]-amine} -3-(phenylpyridine-2-yl-amine)-acide propionique substantiellement pur comme inhibiteur de kinase ikb

Info

Publication number
MA28553B1
MA28553B1 MA29415A MA29415A MA28553B1 MA 28553 B1 MA28553 B1 MA 28553B1 MA 29415 A MA29415 A MA 29415A MA 29415 A MA29415 A MA 29415A MA 28553 B1 MA28553 B1 MA 28553B1
Authority
MA
Morocco
Prior art keywords
purstic
phenylpyridin
pyrimidin
methylamino
indole
Prior art date
Application number
MA29415A
Other languages
English (en)
Inventor
El-Bdaoui Haddad
Olaf Ritzeler
David J Aldous
Paul Joseph Cox
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MA28553B1 publication Critical patent/MA28553B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29415A 2004-05-12 2006-10-27 2-{[2-(2-methylamino-pyrimidine-4-yl)-1h-indole-5-carbonyle]-amine} -3-(phenylpyridine-2-yl-amine)-acide propionique substantiellement pur comme inhibiteur de kinase ikb MA28553B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57014604P 2004-05-12 2004-05-12

Publications (1)

Publication Number Publication Date
MA28553B1 true MA28553B1 (fr) 2007-04-03

Family

ID=34969825

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29415A MA28553B1 (fr) 2004-05-12 2006-10-27 2-{[2-(2-methylamino-pyrimidine-4-yl)-1h-indole-5-carbonyle]-amine} -3-(phenylpyridine-2-yl-amine)-acide propionique substantiellement pur comme inhibiteur de kinase ikb

Country Status (23)

Country Link
EP (1) EP1747215A1 (fr)
JP (1) JP2007537266A (fr)
KR (1) KR20070011483A (fr)
CN (1) CN1950359A (fr)
AR (1) AR049274A1 (fr)
AU (1) AU2005245834A1 (fr)
BR (1) BRPI0511029A (fr)
CA (1) CA2566213A1 (fr)
EC (1) ECSP066992A (fr)
GT (1) GT200500111A (fr)
IL (1) IL178992A0 (fr)
MA (1) MA28553B1 (fr)
MX (1) MXPA06012870A (fr)
NO (1) NO20065719L (fr)
PA (1) PA8633101A1 (fr)
PE (1) PE20060269A1 (fr)
RU (1) RU2006143758A (fr)
SV (1) SV2006002111A (fr)
TN (1) TNSN06338A1 (fr)
TW (1) TW200605881A (fr)
UY (1) UY28897A1 (fr)
WO (1) WO2005113544A1 (fr)
ZA (1) ZA200608712B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951360A1 (de) 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
DE102004033406A1 (de) 2004-07-10 2006-02-16 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
CN104491864A (zh) 2008-04-21 2015-04-08 奥德纳米有限公司 用于治疗耳部疾病和病况的耳用调配物及方法
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2563774B1 (fr) * 2010-04-27 2014-03-12 Hutchison Medipharma Limited Pyrimidinylindoles
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2012120054A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2012120056A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2012120052A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (fr) 2011-03-08 2015-06-24 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2013045413A1 (fr) 2011-09-27 2013-04-04 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
EP3478269A4 (fr) 2016-06-29 2020-04-08 Otonomy, Inc. Formulations otiques à base de triglycérides et leurs utilisations
CN106588803A (zh) * 2016-11-16 2017-04-26 西南科技大学 一种制备5‑乙酰基异噁唑的新方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase

Also Published As

Publication number Publication date
ECSP066992A (es) 2006-12-29
TNSN06338A1 (en) 2008-02-22
PE20060269A1 (es) 2006-05-11
EP1747215A1 (fr) 2007-01-31
AR049274A1 (es) 2006-07-12
RU2006143758A (ru) 2008-06-27
CA2566213A1 (fr) 2005-12-11
KR20070011483A (ko) 2007-01-24
GT200500111A (es) 2006-05-09
WO2005113544A1 (fr) 2005-12-01
NO20065719L (no) 2006-12-12
MXPA06012870A (es) 2007-02-15
IL178992A0 (en) 2007-03-08
BRPI0511029A (pt) 2007-11-27
SV2006002111A (es) 2006-01-30
ZA200608712B (en) 2008-06-25
TW200605881A (en) 2006-02-16
JP2007537266A (ja) 2007-12-20
UY28897A1 (es) 2005-12-30
AU2005245834A1 (en) 2005-12-01
CN1950359A (zh) 2007-04-18
PA8633101A1 (es) 2006-01-23

Similar Documents

Publication Publication Date Title
MA28553B1 (fr) 2-{[2-(2-methylamino-pyrimidine-4-yl)-1h-indole-5-carbonyle]-amine} -3-(phenylpyridine-2-yl-amine)-acide propionique substantiellement pur comme inhibiteur de kinase ikb
HK1126199A1 (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
EP1948193A4 (fr) Aminopyrimidines utiles en tant qu'inhibiteurs de kinases
HK1200164A1 (en) Heterodimers of glutamic acid
ZA200806017B (en) Pyrimidine deivatives used as pi-3 kinase inhibitors
IL202835A0 (en) Pyrimidine derivatives useful as raf kinase inhibitors
HK1133641A1 (zh) 激酶抑製劑化合物
IL194356A0 (en) Novel cyclobutyl compounds as kinase inhibitors
IL193653A0 (en) Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
ZA200906082B (en) Pyrimidine hydrazide compounds as PGDS inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
HRP20130004T8 (en) 4-substituted phenoxyphenylacetic acid derivatives
HK1137295A1 (en) Kinase inhibitor compounds
HK1117504A1 (en) Benzimidazole thiophene compounds as plk inhibitors
PT2231642E (pt) Pirimidinas como inibidores de quinase
PL1703019T3 (pl) Stabilizowany kwasem fosforowym klej krepujący
DK1910267T3 (da) Fremgangsmåde til fremstilling af carboxylsyrealkylestere
EP1713793A4 (fr) Derives de pyrimidinone utiles comme inhibiteurs de kinase
IL194549A0 (en) 2-(pyridin-2-yl)-pyrimidines for use as fungicides
IL201625A0 (en) Arylamide pyrimidone compounds
AU2006259123A8 (en) Spiro-benzimidazoles as inhibitors of gastric acid secretion
DK2225198T3 (da) Fremgangsmåde til fremstilling af en substitueret gamma-aminosyre
EP2125828A4 (fr) Composés de thiéno pyrimidine
DK2010538T3 (da) Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester
ZA200905263B (en) Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors